Walleye Trading LLC Amicus Therapeutics, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $547,463 - $644,129	46,474 New	46,474 $565,000
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $144,858 - $186,016	14,647 Added 217.48%	21,382 $261,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $66,137 - $85,871	6,735 New	6,735 $70,000
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $545,403 - $1.41 Million	59,283 Added 1554.76%	63,096 $623,000
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $77,868 - $95,991	-6,041 Reduced 61.31%	3,813 $54,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $87,306 - $154,609	9,854 New	9,854 $149,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $89,718 - $117,878	-8,186 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $82,187 - $113,949	8,186 New	8,186 $111,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.